Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (80) 80
life sciences & biomedicine (79) 79
rheumatology (65) 65
humans (64) 64
female (43) 43
male (40) 40
systemic lupus erythematosus (38) 38
adult (34) 34
lupus (29) 29
middle aged (21) 21
risk factors (21) 21
mortality (17) 17
young adult (17) 17
immunology (16) 16
adolescent (15) 15
aged (15) 15
cohort studies (14) 14
lupus erythematosus, systemic - ethnology (14) 14
lupus erythematosus, systemic - genetics (14) 14
severity of illness index (14) 14
abridged index medicus (13) 13
autoimmune diseases (13) 13
biological and medical sciences (13) 13
medical sciences (13) 13
genetic predisposition to disease (12) 12
latin america (12) 12
medicin och hälsovetenskap (12) 12
diseases of the osteoarticular system (11) 11
lupus erythematosus, systemic - mortality (11) 11
research (11) 11
disease progression (10) 10
lupus erythematosus, systemic - epidemiology (10) 10
rheumatoid arthritis (10) 10
antiphospholipid syndrome (9) 9
genetic aspects (9) 9
genetics & heredity (9) 9
genotype (9) 9
latin america - epidemiology (9) 9
lupus erythematosus, systemic - complications (9) 9
lupus erythematosus, systemic - drug therapy (9) 9
patients (9) 9
polymorphism, single nucleotide (9) 9
arthritis (8) 8
case-control studies (8) 8
epidemiology (8) 8
ethnicity (8) 8
regression analysis (8) 8
sarcoidosis. granulomatous diseases of unproved etiology. connective tissue diseases. elastic tissue diseases. vasculitis (8) 8
sex factors (8) 8
age factors (7) 7
age of onset (7) 7
antirheumatic agents - therapeutic use (7) 7
haplotypes (7) 7
logistic models (7) 7
longitudinal studies (7) 7
lupus erythematosus, systemic - physiopathology (7) 7
lupus nephritis - ethnology (7) 7
united states - epidemiology (7) 7
african americans (6) 6
age (6) 6
aged, 80 and over (6) 6
alleles (6) 6
analysis (6) 6
autoimmunity (6) 6
european continental ancestry group (6) 6
european continental ancestry group - genetics (6) 6
gender (6) 6
gene expression (6) 6
incidence (6) 6
lupus erythematosus (6) 6
lupus erythematosus, systemic - diagnosis (6) 6
medicine (6) 6
medicine & public health (6) 6
prognosis (6) 6
survival (6) 6
time factors (6) 6
treatment outcome (6) 6
antimalarials - therapeutic use (5) 5
antiphospholipid syndrome - epidemiology (5) 5
care and treatment (5) 5
child (5) 5
disease activity (5) 5
gene frequency (5) 5
genetic variation (5) 5
genetics (5) 5
health aspects (5) 5
immune system diseases (5) 5
immunosuppressive agents - therapeutic use (5) 5
laboratories (5) 5
medical and health sciences (5) 5
multivariate analysis (5) 5
prevalence (5) 5
proportional hazards models (5) 5
quality of life (5) 5
research article (5) 5
socioeconomic factors (5) 5
admixture (4) 4
allergy and immunology (4) 4
antimalarials (4) 4
antiphospholipid antibodies (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)
by Ugarte-Gil, Manuel Francisco and Wojdyla, Daniel and Pons-Estel, Guillermo J and Catoggio, Luis J and Drenkard, Cristina and Sarano, Judith and Berbotto, Guillermo A and Borba, Eduardo F and Sato, Emilia Inoue and Tavares Brenol, João C and Uribe, Oscar and Ramirez Gómez, Luis A and Guibert-Toledano, Marlene and Massardo, Loreto and Cardiel, Mario H and Silveira, Luis H and Chacón-Diaz, Rosa and Alarcón, Graciela S and Pons-Estel, Bernardo A and GLADEL
Annals of the rheumatic diseases, ISSN 0003-4967, 12/2017, Volume 76, Issue 12, pp. 2071 - 2074
systemic lupus erythematosus | low disease activity status | disease damage | outcome | remission | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Severity of Illness Index | Follow-Up Studies | United States | Humans | Risk Factors | Proportional Hazards Models | Hispanic Americans - statistics & numerical data | Male | Treatment Outcome | Lupus Erythematosus, Systemic - mortality | Remission Induction | Disease Progression | Young Adult | Lupus Erythematosus, Systemic - ethnology | Lupus Erythematosus, Systemic - drug therapy | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Prednisone - therapeutic use | Cohort Studies | Regression (Disease) | Care and treatment | Systemic lupus erythematosus | Research | Patient outcomes | Lupus | Socioeconomic factors | Mortality | Remission | Prednisone | Regression analysis | Health risk assessment | Immunosuppressive agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the Literature
by Andreoli, Laura and Chighizola, Cecilia B and Banzato, Alessandra and Pons‐Estel, Guillermo J and Jesus, Guilherme Ramire and Erkan, Doruk and APS ACTION
Arthritis care & research (2010), ISSN 2151-464X, 11/2013, Volume 65, Issue 11, pp. 1869 - 1873
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Morbidity - trends | Myocardial Infarction - epidemiology | Global Health | Humans | Antibodies, Antiphospholipid - immunology | Myocardial Infarction - immunology | Antiphospholipid Syndrome - immunology | Pregnancy | Venous Thrombosis - immunology | Antiphospholipid Syndrome - epidemiology | Venous Thrombosis - epidemiology | Female | Stroke - epidemiology | Pregnancy Complications - epidemiology | Stroke - immunology | Antibodies, Antiphospholipid - analysis | Pregnancy Complications - immunology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text How well do the new classification criteria for SLE perform?
by Pons-Estel, Guillermo J and Alarcón, Graciela S
Nature reviews. Rheumatology, ISSN 1759-4790, 2020, Volume 17, Issue 1, pp. 7 - 8
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Systemic lupus erythematosus | Research | Identification and classification | Immunological research | Decades | Classification | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
by Pons-Estel, Guillermo J., MD and Alarcón, Graciela S., MD, MPH and Scofield, Lacie, MSPH and Reinlib, Leslie, PhD and Cooper, Glinda S., PhD
Seminars in arthritis and rheumatism, ISSN 0049-0172, 2010, Volume 39, Issue 4, pp. 257 - 268
Rheumatology | epidemiology | systemic lupus erythematosus | ethnicity | mortality | disease activity | quality of life | socioeconomic status | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Diseases of the osteoarticular system | United States - epidemiology | Prevalence | Age Factors | Lupus Erythematosus, Systemic - epidemiology | Humans | African Americans | Male | Disease Progression | Incidence | Lupus Erythematosus, Systemic - ethnology | Age of Onset | Sex Factors | Female | Lupus | Development and progression | Systemic lupus erythematosus | Epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Remission or low disease activity as a target in systemic lupus erythematosus
by Ugarte-Gil, Manuel Francisco and Wojdyla, Daniel and Pons-Estel, Guillermo J and Pons-Estel, Bernardo A and Alarcón, Graciela S and GLADEL
Annals of the rheumatic diseases, ISSN 0003-4967, 01/2019, Volume 78, Issue 1, pp. e3 - e3
epidemiology | systemic lupus erythematosus | outcomes research | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Lupus | Remission | Systemic lupus erythematosus | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository
by Unlu, Ozan and Erkan, Doruk and Barbhaiya, Medha and Andrade, Danieli and Nascimento, Iana and Rosa, Renata and Banzato, Alessandra and Pengo, Vittorio and Ugarte, Amaia and Gerosa, Maria and Ji, Lanlan and Efthymiou, Maria and Branch, D. Ware and Jesus, Guilherme Ramires and Tincani, Angela and Belmont, H. Michael and Fortin, Paul R and Petri, Michelle and Rodriguez, Esther and Pons‐Estel, Guillermo J and Knight, Jason S and Atsumi, Tatsuya and Willis, Rohan and Zuily, Stephane and Tektonidou, Maria G and AntiPhospholipid Syndrome All and AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators and the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators
Arthritis care & research (2010), ISSN 2151-464X, 01/2019, Volume 71, Issue 1, pp. 134 - 141
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Antiphospholipid Syndrome - diagnosis | Antibodies, Antiphospholipid - blood | Lupus Erythematosus, Systemic - epidemiology | Humans | Middle Aged | Male | Lupus Erythematosus, Systemic - blood | Lupus Erythematosus, Systemic - diagnosis | Pregnancy | Phenotype | Antiphospholipid Syndrome - epidemiology | Internationality | Adult | Female | Registries | Antiphospholipid Syndrome - blood | Databases, Factual | Lupus | Thrombocytopenia | Phenotypes | Immunoglobulins | Laboratories | Anemia | Immunoglobulin G | Cognitive ability | Clinical trials | Glycoprotein I | Antiphospholipid antibodies | Immunoglobulin A | Thrombosis | Patients | Morbidity | Risk factors | Hemolytic anemia | Systemic lupus erythematosus | Classification | Autoimmune diseases | Cardiovascular diseases | Antiphospholipid syndrome | Smoking | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center
by Serrano, Rosa and Pons-Estel, Guillermo J and Espinosa, Gerard and Quintana, Rosana M and Reverter, Joan C and Tassies, Dolors and Monteagudo, Joan and Cervera, Ricard
Lupus, ISSN 0961-2033, 8/2020, Volume 29, Issue 9, pp. 1050 - 1059
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Demography | Laboratories | Mortality | Fetuses | Pregnancy complications | Births | Abortion | Thrombosis | Hemorrhage | Obstetrics | Patients | Morbidity | Medical prognosis | Endocarditis | Autoimmune diseases | Antiphospholipid syndrome | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text CE-28 Antimalarials protects against thrombosis in patients with systemic lupus erythematosus (SLE): longitudinal data from a large latin american cohort
by Pons-Estel, Guillermo J and Alarcón, Graciela S and Daniel, Wojdyla and Ugarte-Gil, Manuel F and Magder, Laurence S and Marcos, Ana I and Drenkard, Cristina and Alvarellos, Alejandro J and Bonfa, Eloisa and Costallat, Lilian Lavras and Massardo, Loreto and Iglesias-Gamarra, Antonio A and Guibert-Toledano, Marlene and Amigo, Mary Carmen and Cardiel, Mario H and Huerta-Yañez, Guillermo F and Esteva-Spinetti, María H and Pons-Estel, Bernardo A
Lupus science & medicine, 09/2016, Volume 3, Issue Suppl 1, p. A61
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Lupus in Latin-American patients: lessons from the GLADEL cohort
by Pons-Estel, G J and Catoggio, L J and Cardiel, M H and Bonfa, E and Caeiro, F and Sato, E and Massardo, L and Molina-Restrepo, J F and Toledano, M Guibert and Barile-Fabris, L A and Amigo, M C and Acevedo-Vásquez, E M and Abadi, I and Wojdyla, D and Alarcón-Riquelme, M E and Alarcón, G S and Pons-Estel, B A and GLADEL
5/2015, Volume 24, Issue 6, 10
renal lupus | cardiovascular disease | Systemic lupus erythematosus | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Latin America - epidemiology | Regression Analysis | Lupus Erythematosus, Systemic - epidemiology | Humans | Logistic Models | Lupus Erythematosus, Discoid - epidemiology | Lupus Nephritis - epidemiology | Index Medicus | Medicin och hälsovetenskap
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: Data from a Latin American cohort
by Pons-Estel, GJ and Alarcón, GS and Burgos, PI and Hachuel, L and Boggio, G and Wojdyla, D and Nieto, R and Alvarellos, A and Catoggio, LJ and Guibert-Toledano, M and Sarano, J and Massardo, L and Vásquez, GM and Iglesias-Gamarra, A and Costallat, LT Lavras and Da Silva, NA and Alfaro, JL and Abadi, I and Segami, MI and Huerta, G and Cardiel, MH and Pons-Estel, BA and GLADEL and Grupo Latino Americano de Estudio de Lupus (GLADEL)
Lupus, ISSN 0961-2033, 8/2013, Volume 22, Issue 9, pp. 899 - 907
nephritis | antimalarials | systemic lupus erythematosus | ethnicity | renal lupus | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Multivariate Analysis | Follow-Up Studies | Humans | Male | Young Adult | Time Factors | Lupus Erythematosus, Systemic - ethnology | Lupus Erythematosus, Systemic - drug therapy | Lupus Nephritis - ethnology | Adult | Female | Hypertension - epidemiology | Latin America - epidemiology | Severity of Illness Index | Photosensitivity Disorders - epidemiology | Risk Factors | Proportional Hazards Models | Antimalarials - therapeutic use | Regression Analysis | Antimalarials - administration & dosage | Adolescent | Age of Onset | Lupus Erythematosus, Systemic - physiopathology | Longitudinal Studies | Cohort Studies | Lupus Nephritis - prevention & control | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort
by Quintana, Rosana and Pons-Estel, Guillermo J and Roberts, Karen and Sacnún, Mónica and Serrano, Rosa and Nieto, Romina and Conti, Silvana and Gervasoni, Viviana and Catoggio, Luis J and Soriano, Enrique R and Scolnik, Marina and García, Mercedes A and Alvarellos, Alejandro and Saurit, Verónica and Berbotto, Guillermo A and Sato, Emilia I and Costallat, Lilian T Lavras and Neto, Eduardo Ferreira Borba and Bonfa, Eloisa and Xavier, Ricardo M and de Oliveira e Silva Montandon, Ana Carolina and Molina-Restrepo, José Fernando and Iglesias-Gamarra, Antonio and Guibert-Toledano, Marlene and Reyes-Llerena, Gil Alberto and Massardo, Loreto and Neira, Oscar J and Cardiel, Mario H and Barile-Fabris, Leonor A and Amigo, Mary-Carmen and Silveira, Luis H and Torre, Ignacio García De La and Acevedo-Vásquez, Eduardo M and Ugarte-Gil, Manuel F and Alfaro-Lozano, José Luis and Segami, María Inés and Chacón-Díaz, Rosa and Esteva-Spinetti, María H and Gomez-Puerta, José A and Alarcón, Graciela S and Pons-Estel, Bernardo A and Grp Latinoamer Estudio Lupus GLADE
Lupus, ISSN 0961-2033, 8/2020, Volume 29, Issue 9, pp. 1140 - 1145
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Lupus | Pericarditis | Systemic lupus erythematosus | Survival | Mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights